Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT with 5-FU and Mitomycin C for Anal Canal Carcinoma
NCT00423293Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Dec 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of fluorouracil and mitomycin c in anal canal carcinoma (SCCA), sponsored by NRG Oncology. Started Dec 2006; status: completed.
02
Drugs
fluorouracilmitomycin c
03
Conditions
anal canal carcinoma (SCCA)
Beyond the preview
Go deeper on NCT00423293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423293.